Health Care & Life Sciences » Biotechnology | Dyadic International Inc.

Dyadic International Inc.

Dyadic International Inc.
Stock Exchange Other OTC
EPS
$0.22
Market Cap
$155.76 M
Shares Outstanding
26.76 M
Public Float
22.8 M

Profile

Address
140 Intracoastal Pointe Drive
Jupiter Florida 33477
United States
Employees -
Website http://www.dyadic.com
Updated 07/08/2019
Dyadic International, Inc. operates as a biotechnology company. It uses its patented and proprietary technologies for the discovery, development, manufacture, and sale of enzymes and other proteins for the bioenergy, biochemical, biopharmaceutical, and industrial enzyme industries. The company was founded by Mark A.

Financials

View All
Created with Highcharts 5.0.14Dyadic International Inc.Net Income. Fiscal year is January-December. All values USD Thousands.4284285 9805 9801 4651 4653 6083 6082 1352 1355 6915 69120132014201520162017201801k2k3k4k5k6k7k
Created with Highcharts 5.0.14Dyadic International Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.17 13417 13412 52312 5233153155925927587581 2951 29520132014201520162017201805k10k15k20k

Mark A. Emalfarb
President, Chief Executive Officer & Director
Barry C. Buckland
Director